Which has grown faster, LMAT or SGRY?

Over the past five years, LMAT grew revenue faster — LMAT at a 11.76% CAGR versus SGRY at 9.90%.

Does LMAT or SGRY pay a bigger dividend?

LMAT pays a dividend (1.17% yield), while SGRY has no payments in the available dividend history.

Is LMAT or SGRY more profitable?

LMAT runs the higher net margin — LMAT at 25.02% versus SGRY at -2.63%.

How have LMAT and SGRY total returns compared?

Over the past 10 years, LMAT delivered 16.21% and SGRY delivered -3.96% annualized total return. Past performance doesn't predict future results.

LeMaitre Vascular, Inc. (LMAT) vs Surgery Partners, Inc. (SGRY)

A side-by-side comparison of LeMaitre Vascular, Inc. and Surgery Partners, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

LMAT

LeMaitre Vascular, Inc.

$1.82B

$79.43HealthcareDelayed quote: Oct 6, 2026, 1:54 PM EDT

SGRY

Surgery Partners, Inc.

$1.75B

$13.42HealthcareDelayed quote: Oct 6, 2026, 1:50 PM EDT

Total return — LMAT vs SGRY

growth of $100 · dividends reinvested · last 10y

LMAT +349.0% (+16.2%/yr)SGRY -33.5% (-4.0%/yr)LMAT compounded faster over this window

Log scale — wide-divergence pair

LMAT SGRY

LMAT vs SGRY: by the numbers

•LMAT is the larger company ($1.82B vs $1.75B market cap).
•LMAT is profitable (25.02% net margin) while SGRY runs a net loss (-2.63%).
•LMAT grew revenue faster over the past five years (11.76% vs 9.90% CAGR).
•LMAT pays a dividend (1.17% yield), while SGRY has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	LMAT	SGRY
P/E ratio	27.87	N/A
Forward P/E	27.65	32.96
PEG ratio	1.44	N/A
P/S ratio	6.92	0.52
P/B ratio	4.32	1.05
EV / EBITDA	21.77	9.62
FCF yield	4.07%	10.69%

Profitability

Metric	LMAT	SGRY
Gross margin	72.90%	21.37%
Operating margin	29.46%	11.89%
Net margin	25.02%	-2.63%
ROE	15.62%	-5.30%
ROIC	9.81%	4.23%

Dividends

Metric	LMAT	SGRY
Dividend yield	1.17%	N/A
Payout ratio	33.33%	N/A

Growth (annualized)

Metric	LMAT	SGRY
Revenue CAGR (5Y)	11.76%	9.90%
EPS CAGR (5Y)	19.42%	N/A
FCF CAGR (5Y)	13.06%	-0.84%
Total return CAGR (5Y)	9.79%	-20.85%

Frequently asked

Which has grown faster, LMAT or SGRY?: Over the past five years, LMAT grew revenue faster — LMAT at a 11.76% CAGR versus SGRY at 9.90%.
Does LMAT or SGRY pay a bigger dividend?: LMAT pays a dividend (1.17% yield), while SGRY has no payments in the available dividend history.
Is LMAT or SGRY more profitable?: LMAT runs the higher net margin — LMAT at 25.02% versus SGRY at -2.63%.
How have LMAT and SGRY total returns compared?: Over the past 10 years, LMAT delivered 16.21% and SGRY delivered -3.96% annualized total return. Past performance doesn't predict future results.

Go deeper

Full LMAT analysis Full SGRY analysis Interactive comparison tool

Dig into the metrics

LeMaitre Vascular P/E ratio LeMaitre Vascular dividend yield LeMaitre Vascular ROE Surgery Partners ROE LeMaitre Vascular operating margin Surgery Partners operating margin LeMaitre Vascular revenue growth Surgery Partners revenue growth LeMaitre Vascular free cash flow Surgery Partners free cash flow

LeMaitre Vascular & Surgery Partners appear in these rankings

Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.